ID24174A - Vector dari porcine adenovirus - Google Patents

Vector dari porcine adenovirus

Info

Publication number: ID24174A
Authority: ID; Indonesia
Prior art keywords: porcine adenovirus; recombinant; vector; nucleotide sequence; methods
Prior art date: 1997-08-14

Application number

IDW20000491A

Other languages

English (en)

Inventor

Michael Johnson

J M Hammond

Original Assignee

Commw Scient Ind Res Org

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-08-14

Filing date

1998-08-14

Publication date

2000-07-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3802849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID24174(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-08-14 Application filed by Commw Scient Ind Res Org filed Critical Commw Scient Ind Res Org

2000-07-13 Publication of ID24174A publication Critical patent/ID24174A/id

Links

239000013598 vector Substances 0.000 title abstract 4
241000188845 Porcine adenovirus Species 0.000 title abstract 2
238000000034 method Methods 0.000 abstract 3
239000002773 nucleotide Substances 0.000 abstract 2
125000003729 nucleotide group Chemical group 0.000 abstract 2
241000710777 Classical swine fever virus Species 0.000 abstract 1
241000701093 Suid alphaherpesvirus 1 Species 0.000 abstract 1
241000282887 Suidae Species 0.000 abstract 1
230000000890 antigenic effect Effects 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/235—Adenoviridae
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Virology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Toxicology (AREA)
Physics & Mathematics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Plant Pathology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IDW20000491A 1997-08-14 1998-08-14 Vector dari porcine adenovirus ID24174A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
AUPO8560A AUPO856097A0 (en)	1997-08-14	1997-08-14	Vector

Publications (1)

Publication Number	Publication Date
ID24174A true ID24174A (id)	2000-07-13

Family

ID=3802849

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20000491A ID24174A (id)	1997-08-14	1998-08-14	Vector dari porcine adenovirus

Country Status (17)

Country	Link
US (3)	US7323177B1 (id)
EP (2)	EP1825863A1 (id)
JP (2)	JP4365023B2 (id)
KR (1)	KR100746524B1 (id)
CN (1)	CN100366292C (id)
AT (1)	ATE357250T1 (id)
AU (2)	AUPO856097A0 (id)
BR (1)	BR9811184A (id)
CY (1)	CY1106565T1 (id)
DE (1)	DE69837390T2 (id)
DK (1)	DK1007088T3 (id)
ES (1)	ES2283068T3 (id)
ID (1)	ID24174A (id)
MX (1)	MXPA00001562A (id)
NZ (1)	NZ503039A (id)
PT (1)	PT1007088E (id)
WO (1)	WO1999008706A1 (id)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPO856097A0 (en) *	1997-08-14	1997-09-04	Commonwealth Scientific And Industrial Research Organisation	Vector
US6492343B1 (en) *	1998-04-15	2002-12-10	University Of Saskatchewan	Porcine adenovirus type 3 genome
FR2789695B1 (fr)	1999-02-11	2003-03-07	Merial Sas	Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
FR2804028B1 (fr) *	2000-01-21	2004-06-04	Merial Sas	Vaccins adn ameliores pour animaux de rente
WO2001083737A2 (en) *	2000-05-03	2001-11-08	University Of Guelph	Porcine adenovirus type 5 vector and vaccine
WO2002031168A2 (en) *	2000-10-10	2002-04-18	Genstar Therapeutics	Minimal adenoviral vector and recombinant vaccines based thereon
MY146518A (en)	2001-03-27	2012-08-15	Univ Saskatchewan	Methods to culture circovirus.
WO2003013598A2 (en) *	2001-08-09	2003-02-20	Lam Dominic M K	Novel vaccine compositions and methods of vaccine preparation for veterinary and human diseases
WO2003023026A1 (en)	2001-09-06	2003-03-20	Alphavax, Inc.	Alphavirus replicon vector systems
JP3949520B2 (ja) *	2001-09-20	2007-07-25	独立行政法人科学技術振興機構	レギュカルチン過剰発現モデル動物
US7569217B2 (en)	2001-09-24	2009-08-04	University Of Saskatchewan	Porcine adenovirus E1 and E4 regions
KR20030054139A (ko) *	2001-12-24	2003-07-02	학교법인 건국대학교	돼지 오제스키병 바이러스의 ｇＤ 유전자를 포함하는재조합 발현 벡터 및 이를 이용한 ＤＮＡ 백신
US7906311B2 (en)	2002-03-20	2011-03-15	Merial Limited	Cotton rat lung cells for virus culture
AU2003297039B2 (en)	2002-12-13	2009-03-05	Alphavax, Inc.	Multi-antigenic alphavirus replicon particles and methods
AU2003297041B2 (en)	2002-12-13	2009-02-26	Alphavax, Inc.	Alphavirus particles and methods for preparation
EP1608762B1 (en)	2003-03-20	2014-01-08	Alphavax, Inc.	Improved alphavirus replicons and helper constructs
PT1651666E (pt)	2003-07-11	2009-08-28	Alphavax Inc	Vacinas de citomegalovírus à base de alfavírus
PT1751289E (pt)	2004-05-18	2009-03-31	Alphavax Inc	Vectores de alfavirais derivados da tc-83, partículas e métodos
CN101277717A (zh) *	2005-09-09	2008-10-01	英特威国际有限公司	Pcv-2疫苗
CN101849012A (zh) *	2006-07-28	2010-09-29	联邦科学和工业研究组织	用于增加重组腺病毒载体的组织嗜性的方法和组合物
DK2947149T3 (en)	2007-06-21	2018-06-06	Alphavax Inc	ALPHAVIRUS REPLICATION PARTICLES FOR USE IN VACCINATION
US20100150959A1 (en) *	2008-12-15	2010-06-17	Vectogen Pty Ltd.	PCV 2-Based Methods and Compositions for the Treatment of Pigs
US20110135688A1 (en) *	2009-12-04	2011-06-09	Michael Sheppard	Methods and Compositions for Increasing Titer of Recombinant Porcine Adenovirus-3 Vectors
MX2014013964A (es) *	2012-05-17	2015-03-04	Zoetis Llc	Vacunacion eficaz contral el virus del sindrome reproductivo y respiratorio porcino (prrs) antes del destete.
EP3107568B1 (en) *	2014-02-20	2024-03-27	Vaxart, Inc.	Formulations for small intestinal delivery
KR102678401B1 (ko)	2015-06-12	2024-06-26	박사르트, 인크.	Rsv 및 노로바이러스 항원들의 소장 내의 전달을 위한 제형들
UA124976C2 (uk)	2016-12-14	2021-12-22	Зоетіс Сервісіз Ллс	Вакцина для захисту тварини свині від зараження вірусом prrs
CN110904127B (zh) *	2018-09-18	2024-09-20	瓦赫宁恩研究基金会	非洲猪瘟病毒疫苗
WO2022155500A1 (en)	2021-01-14	2022-07-21	Senti Biosciences, Inc.	Secretable payload regulation
CN116004550A (zh) *	2022-08-03	2023-04-25	石河子大学	猪轮状病毒重组腺病毒及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4320068C1 (de)	1993-06-17	1994-12-15	Audi Ag	Verfahren und Vorrichtung zur Reparatur von Fahrzeugkarosserien aus Leichtmetallteilen
CA2144040A1 (fr) *	1993-07-13	1995-01-26	Michel Perricaudet	Vecteurs adenoviraux defectifs et utilisation en therapie genique
WO1996002697A1 (en)	1994-07-14	1996-02-01	Union Camp Patent Holding, Inc.	Improved bleaching of high consistency lignocellulosic pulp
FR2725213B1 (fr) *	1994-10-04	1996-11-08	Rhone Poulenc Rorer Sa	Vecteurs viraux et utilisation en therapie genique
ES2105984B1 (es) *	1995-11-30	1998-04-16	Iberica Cyanamid	Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.
AUPO856097A0 (en) *	1997-08-14	1997-09-04	Commonwealth Scientific And Industrial Research Organisation	Vector
US6492343B1 (en) *	1998-04-15	2002-12-10	University Of Saskatchewan	Porcine adenovirus type 3 genome

1997
- 1997-08-14 AU AUPO8560A patent/AUPO856097A0/en not_active Abandoned
1998
- 1998-08-14 WO PCT/AU1998/000648 patent/WO1999008706A1/en not_active Ceased
- 1998-08-14 US US09/485,512 patent/US7323177B1/en not_active Expired - Fee Related
- 1998-08-14 DK DK98938527T patent/DK1007088T3/da active
- 1998-08-14 EP EP07005454A patent/EP1825863A1/en not_active Withdrawn
- 1998-08-14 DE DE69837390T patent/DE69837390T2/de not_active Expired - Lifetime
- 1998-08-14 ID IDW20000491A patent/ID24174A/id unknown
- 1998-08-14 MX MXPA00001562A patent/MXPA00001562A/es active IP Right Grant
- 1998-08-14 EP EP98938527A patent/EP1007088B1/en not_active Expired - Lifetime
- 1998-08-14 NZ NZ503039A patent/NZ503039A/xx not_active IP Right Cessation
- 1998-08-14 AT AT98938527T patent/ATE357250T1/de active
- 1998-08-14 JP JP2000509443A patent/JP4365023B2/ja not_active Expired - Fee Related
- 1998-08-14 CN CNB98809116XA patent/CN100366292C/zh not_active Expired - Fee Related
- 1998-08-14 KR KR1020007001486A patent/KR100746524B1/ko not_active Expired - Fee Related
- 1998-08-14 ES ES98938527T patent/ES2283068T3/es not_active Expired - Lifetime
- 1998-08-14 PT PT98938527T patent/PT1007088E/pt unknown
- 1998-08-14 BR BR9811184-1A patent/BR9811184A/pt not_active IP Right Cessation
2006
- 2006-03-22 US US11/387,026 patent/US7473428B2/en not_active Expired - Fee Related
2007
- 2007-05-07 CY CY20071100603T patent/CY1106565T1/el unknown
2008
- 2008-08-22 US US12/197,056 patent/US7785602B2/en not_active Expired - Fee Related
2009
- 2009-07-01 JP JP2009156467A patent/JP2009213495A/ja active Pending
2011
- 2011-09-09 AU AU2011224111A patent/AU2011224111A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO1999008706A8 (en)	2000-08-10
ES2283068T3 (es)	2007-10-16
EP1825863A1 (en)	2007-08-29
EP1007088B1 (en)	2007-03-21
AU2011224111A1 (en)	2011-10-13
US7323177B1 (en)	2008-01-29
BR9811184A (pt)	2001-12-26
DK1007088T3 (da)	2007-06-04
DE69837390D1 (de)	2007-05-03
EP1007088A4 (en)	2003-01-08
CN1275084A (zh)	2000-11-29
JP4365023B2 (ja)	2009-11-18
WO1999008706A1 (en)	1999-02-25
ATE357250T1 (de)	2007-04-15
CN100366292C (zh)	2008-02-06
MXPA00001562A (es)	2004-10-14
EP1007088A1 (en)	2000-06-14
US20090226485A1 (en)	2009-09-10
KR20010022882A (ko)	2001-03-26
HK1032755A1 (zh)	2001-08-03
NZ503039A (en)	2002-09-27
KR100746524B1 (ko)	2007-08-07
JP2009213495A (ja)	2009-09-24
US7473428B2 (en)	2009-01-06
US7785602B2 (en)	2010-08-31
CY1106565T1 (el)	2012-01-25
PT1007088E (pt)	2007-05-31
JP2001514871A (ja)	2001-09-18
US20060263387A1 (en)	2006-11-23
AUPO856097A0 (en)	1997-09-04
DE69837390T2 (de)	2007-08-23

Publication	Publication Date	Title
DK1007088T3 (da)	2007-06-04	Rekombinant svine-adenovirusvektor
DE69632235D1 (de)	2004-05-27	Newcastle-Krankheitsvirus-Kombinationsimpfstoff
ATE292685T1 (de)	2005-04-15	Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
AU9063801A (en)	2002-03-22	Methods and compositions for diseases associated with amyloidosis
NO20001768D0 (no)	2000-04-06	Viruskapsomervaksine, fremgangsmåte til fremstilling samt anvendelse derav
ATE476510T1 (de)	2010-08-15	Schweine-circovirus-impfstoff in rekombinantem pockenvirus
CY1107570T1 (el)	2013-03-13	Ανοσογονικα πολυπεπτιδια κωδικοποιουμενα απο μινιγονιδια mage και οι χρησεις τους
BR9708401A (pt)	2000-01-04	Vetores de vìrus de para-varìola
DE69101646D1 (de)	1994-05-19	Vakzine gegen Coccidiose.
NL300336I2 (nl)	2009-01-05	Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
DE69738641D1 (de)	2008-05-29	Lebend-impfstoff gegen heliobacter pylori
EP0236977A3 (en)	1989-05-03	Bovine virus diarrhea and hog cholera vaccines
BR0007855A (pt)	2001-10-23	Vacina de vìrus eliminado o gene bhv-1
BR9508645B1 (pt)	2009-01-13	seqÜÊncia de nucleotÍdeos isolada compreendendo o gene s fipv tendo uma seqÜencia de nucleotÍdeos da cepa 79-1146 fipv, bem como polipeptÍdeo, vacina e composiÇço compreendendo a mesma.
GR3029665T3 (en)	1999-06-30	16 kDa SURFACE PROTEIN OF -i(P. FALCIPARUM).
EP1090995A3 (en)	2001-04-18	Mycoplasma hyopneumoniae antigen MHP3, gene encoding it and uses thereof
NZ227943A (en)	1991-08-27	An antigen derived from the neck region of the rhoptries of merozoites and vaccine against plasmodium falciparum
ZA906667B (en)	1991-06-26	Antigens and polypeptides derived from babesia(12d3 antigen)